4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof

Details for Australian Patent Application No. 2004293415 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Jung, Jae-Kyu; Johnson, Benjamin R.; Semple, Graeme

Agent FB Rice

Pub. Number AU-A-2004293415

PCT Pub. Number WO2005/051937

Priority 60/524,269 21.11.03 US

Filing date 18 November 2004

Wipo publication date 9 June 2005

International Classifications

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051937 Priority application(s): WO2005/051937

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293416-Benzylether and benzylamino betasecretase inhibitors for the treatment of Alzheimer's disease

2004293410-Flexible carrier having regions of higher and lower corona treatment